Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Anticipated Shortage

VANFLYTA

DAIICHI SANKYO PHARMA CANADA LIMITED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of VANFLYTA in Canada?

A shortage of VANFLYTA 26.5MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 10, 2026), but it has not started yet.

When will VANFLYTA be available again?

The manufacturer's estimated resolution date is October 15, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusAnticipated Shortage
Same-ingredient products on fileNone found
Expected resolution~17 days remaining (estimate)
Affected strength26.5MG
Last updated2026-09-10

What this means

Does this mean my pharmacy is already out of stock?

No — this shortage hasn't started yet. It's an early warning that supply may become tight, based on information from the manufacturer.

What should I do?

No action is needed yet. It's worth asking your pharmacist at your next refill whether they expect any disruption for this product.

DIN

02558378

Strength

26.5MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

QUIZARTINIB

See all QUIZARTINIB products →

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

Other Products from DAIICHI SANKYO PHARMA CANADA LIMITED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.